- call +1-201-465-4211
- email sales@mrinsights.biz
Attention Deficit Hyperactivity Disorder (ADHD) is a brain disorder marked by an ongoing pattern of inattention and/or hyperactivity-impulsivity that interferes with functioning or development. It may begin in early childhood and can continue into adulthood. Without treatment, ADHD can cause problems at home, at school, at work, and with relationships. In the past, ADHD was termed as Attention Deficit Disorder (ADD). The exact cause is not known, but ADHD tends to run in families. Boys are about three times more likely than girls to be diagnosed with it.
Scope of the Report:
For many people, ADHD medications reduce hyperactivity and impulsivity and improve their ability to focus, work, and learn. On the basis of medication the market size covers Stimulants (Amphetamine, Methylphenidate, Dextroamphetamine, Dexmethylphenidate, and Lisdexamfetamine Dimesylate): Stimulant is the most common type of medication used for treating ADHD. It increases the brain chemicals dopamine and norepinephrine, which play important roles in thinking and attention; Non-stimulants (Atomoxetine, Bupropion, Guanfacine, and Clonidine): These medications take longer to start working than stimulants, but can also improve focus, attention, and impulsivity in a person with ADHD. Although not approved by the U.S. Food and Drug Administration (FDA) specifically for the treatment of ADHD, some antidepressants are sometimes used alone or in combination with a stimulant to treat ADHD.
The global Attention Deficit Hyperactivity Disorder (ADHD) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Attention Deficit Hyperactivity Disorder (ADHD).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Attention Deficit Hyperactivity Disorder (ADHD) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Attention Deficit Hyperactivity Disorder (ADHD) market by product type and applications/end industries.
Market Segment by Companies, this report covers
Shire
Neos Therapeutics
Eli Lilly
Pfizer
Alcobra
Supernus Pharmaceuticals
Noven Pharmaceuticals
Novartis
Johnson & Johnson
Curemark
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Stimulants
Non-Stimulants
Market Segment by Applications, can be divided into
Specialty Clinics
Hospital
Retail
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Attention Deficit Hyperactivity Disorder (ADHD) Market Overview
1.1 Product Overview and Scope of Attention Deficit Hyperactivity Disorder (ADHD)
1.2 Classification of Attention Deficit Hyperactivity Disorder (ADHD) by Types
1.2.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Comparison by Types (2017-2023)
1.2.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Types in 2017
1.2.3 Stimulants
1.2.4 Non-Stimulants
1.3 Global Attention Deficit Hyperactivity Disorder (ADHD) Market by Application
1.3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Specialty Clinics
1.3.3 Hospital
1.3.4 Retail
1.4 Global Attention Deficit Hyperactivity Disorder (ADHD) Market by Regions
1.4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Attention Deficit Hyperactivity Disorder (ADHD) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Attention Deficit Hyperactivity Disorder (ADHD) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Attention Deficit Hyperactivity Disorder (ADHD) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Attention Deficit Hyperactivity Disorder (ADHD) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Attention Deficit Hyperactivity Disorder (ADHD) Status and Prospect (2013-2023)
1.5 Global Market Size of Attention Deficit Hyperactivity Disorder (ADHD) (2013-2023)
2 Manufacturers Profiles
2.1 Shire
2.1.1 Business Overview
2.1.2 Attention Deficit Hyperactivity Disorder (ADHD) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Shire Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Neos Therapeutics
2.2.1 Business Overview
2.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Neos Therapeutics Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Eli Lilly
2.3.1 Business Overview
2.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Attention Deficit Hyperactivity Disorder (ADHD) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Pfizer Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Alcobra
2.5.1 Business Overview
2.5.2 Attention Deficit Hyperactivity Disorder (ADHD) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Alcobra Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Supernus Pharmaceuticals
2.6.1 Business Overview
2.6.2 Attention Deficit Hyperactivity Disorder (ADHD) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Supernus Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Noven Pharmaceuticals
2.7.1 Business Overview
2.7.2 Attention Deficit Hyperactivity Disorder (ADHD) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Noven Pharmaceuticals Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Attention Deficit Hyperactivity Disorder (ADHD) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Johnson & Johnson
2.9.1 Business Overview
2.9.2 Attention Deficit Hyperactivity Disorder (ADHD) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2016-2017)
2.10 Curemark
2.10.1 Business Overview
2.10.2 Attention Deficit Hyperactivity Disorder (ADHD) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Curemark Attention Deficit Hyperactivity Disorder (ADHD) Revenue, Gross Margin and Market Share (2016-2017)
3 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Competition, by Players
3.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Attention Deficit Hyperactivity Disorder (ADHD) Players Market Share
3.2.2 Top 10 Attention Deficit Hyperactivity Disorder (ADHD) Players Market Share
3.3 Market Competition Trend
4 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size by Regions
4.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Market Share by Regions
4.2 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
4.3 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
4.5 South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
5 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries
5.1 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2013-2018)
5.2 USA Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
5.3 Canada Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
5.4 Mexico Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
6 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries
6.1 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2013-2018)
6.2 Germany Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
6.3 UK Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
6.4 France Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
6.5 Russia Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
6.6 Italy Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries
7.1 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2013-2018)
7.2 China Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
7.3 Japan Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
7.4 Korea Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
7.5 India Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
8 South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries
8.1 South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2013-2018)
8.2 Brazil Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
8.3 Argentina Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
8.4 Colombia Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Attention Deficit Hyperactivity Disorder (ADHD) by Countries
9.1 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
9.3 UAE Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
9.4 Egypt Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
9.6 South Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Growth Rate (2013-2018)
10 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Segment by Type
10.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue and Market Share by Type (2013-2018)
10.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast by Type (2018-2023)
10.3 Stimulants Revenue Growth Rate (2013-2023)
10.4 Non-Stimulants Revenue Growth Rate (2013-2023)
11 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Segment by Application
11.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Share by Application (2013-2018)
11.2 Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast by Application (2018-2023)
11.3 Specialty Clinics Revenue Growth (2013-2018)
11.4 Hospital Revenue Growth (2013-2018)
11.5 Retail Revenue Growth (2013-2018)
12 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Forecast (2018-2023)
12.1 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size Forecast (2018-2023)
12.2 Global Attention Deficit Hyperactivity Disorder (ADHD) Market Forecast by Regions (2018-2023)
12.3 North America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2018-2023)
12.4 Europe Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2018-2023)
12.6 South America Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Attention Deficit Hyperactivity Disorder (ADHD) Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Attention Deficit Hyperactivity Disorder (ADHD) Picture
Table Product Specifications of Attention Deficit Hyperactivity Disorder (ADHD)
Table Global Attention Defici
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
